Data on IL-6 concentrations collected in Table 3 allow a conclusion that in control groups, comprising patients with benign gynecological conditions, IL-6 concentrations were significantly lower than in patients with ovarian cancer. This evidence concerns the gene IL6 and ovarian carcinoma.